In a bid to sustain a strong balance sheet and lower the debt load, Core Labs (CLB) trims its quarterly cash dividend to a penny per share from the prior dividend of 25 cents.
Brokerages expect Core Laboratories (NYSE:CLB) to report sales of $151.62 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Core Lab
Core Laboratories (NYSE:CLB) -3.7% after-hours following a slight Q1 earnings miss on a 10% Y/Y revenue decline to $152M.The company says Q1 free cash flow totaled $18.7M, marking the 74th consecutive

Core Laboratories (CLB) Lags Q1 Earnings Estimates

10:25pm, Wednesday, 22'nd Apr 2020
Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Lags Q1 Earnings Estimates

10:25pm, Wednesday, 22'nd Apr 2020
Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories: 1Q Earnings Snapshot

09:17pm, Wednesday, 22'nd Apr 2020
AMSTERDAM (AP) _ Core Laboratories NV (CLB) on Wednesday reported a first-quarter loss of $108.4 million, after reporting a profit in the same period a year earlier. The Amsterdam-based company said i
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in first quarter 2020 revenue of $152,400,0
Shares of oil-field service providers are moving higher today, but the outlook remains incredibly bleak.
Core Laboratories reports COVID-19 impact mitigation measures CLB
Core Laboratories reports Q1 adjusted EPS 31c, consensus 35c CLB

Core Laboratories Q1 2020 Earnings Preview

09:35pm, Tuesday, 21'st Apr 2020
Core Laboratories (NYSE:CLB) is scheduled to announce Q1 earnings results on Wednesday, April 22nd, after market close.The consensus EPS Estimate is $0.33 (-25.0% Y/Y) and the consensus Revenue Estima
Douglas Lane & Associates LLC grew its holdings in shares of Core Laboratories (NYSE:CLB) by 39.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 377,565 shar
Core Laboratories (NYSE:CLB) had its target price decreased by analysts at Scotiabank from $40.00 to $13.00 in a report released on Sunday, Benzinga reports. Scotiabank’s target price indicates a po
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE